학술논문

Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults
Document Type
Article
Source
In: Clinical Infectious Diseases. (Clinical Infectious Diseases, 15 April 2024, 78(4):870-879)
Subject
Language
English
ISSN
15376591
10584838